willow health glp-1 Willow’s so-called bootlegged “semaglutide tablets”

I.TorresM

A Potentially Serious Adverse Effect of GLP-1 Receptor Agonists

5H) levels were significantly reduced in the renal tissues of DAPA-treated mice compared with the DN group, indicating a mitigated ferroptosis phenotype

Individuals with any of the following conditions should consult with their healthcare provider before use and may not be eligible for treatment: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Known hypersensitivity to GLP-1 or GLP-1/GIP medications or any formulation components, including additives such as vitamin B12 or cobalt Pregnancy or plans to become pregnant (therapy should be discontinued at least two months prior to planned pregnancy) Diabetic ketoacidosis (DKA) or type 1 diabetes Severe gastrointestinal disease (including gastroparesis or active inflammatory bowel disease) Severe cardiovascular disease (including unstable coronary artery disease or heart failure) Recent bariatric or gastrointestinal surgery within the past six months Active cancer currently undergoing chemotherapy or radiation treatment This list is not comprehensive

& Strasser, A

Can I join Mochi if I have pre-diabetes, diabetes, hypertension, or other pre-existing conditions